Fiduciary Trust International of Pennsylvania’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$13M Buy
170,788
+2,274
+1% +$194K 0.61% 51
2019
Q4
$14.9M Sell
168,514
-5,672
-3% -$471K 0.55% 45
2019
Q3
$13.2M Sell
174,186
-2,790
-2% -$191K 0.52% 57
2019
Q2
$12.9M Sell
176,976
-4,461
-2% -$351K 0.53% 54
2019
Q1
$14.6M Sell
181,437
-3,308
-2% -$271K 0.62% 41
2018
Q4
$17M Sell
184,745
-17,168
-9% -$1.51M 0.85% 36
2018
Q3
$19.1M Sell
201,913
-54,776
-21% -$5.19M 0.8% 36
2018
Q2
$23.8M Buy
256,689
+324
+0.1% +$31.6K 1.07% 22
2018
Q1
$24.3M Buy
256,365
+8,594
+3% +$944K 1.13% 18
2017
Q4
$24M Sell
247,771
-13,270
-5% -$1.25M 1.07% 20
2017
Q3
$23.2M Buy
261,041
+16,046
+7% +$1.22M 1.12% 25
2017
Q2
$17.8M Buy
244,995
+136,876
+127% +$9.2M 0.88% 24
2017
Q1
$7.04M Sell
108,119
-19,707
-15% -$1.24M 0.53% 59
2016
Q4
$8M Sell
127,826
-20,846
-14% -$1.27M 0.63% 47
2016
Q3
$9.38M Buy
148,672
+18,101
+14% +$1.17M 0.76% 37
2016
Q2
$8.08M Sell
130,571
-3,019
-2% -$184K 0.66% 47
2016
Q1
$7.63M Buy
133,590
+6,809
+5% +$380K 0.65% 50
2015
Q4
$7.51M Sell
126,781
-49,829
-28% -$2.87M 0.64% 54
2015
Q3
$9.61M Sell
176,610
-31,724
-15% -$2.07M 0.9% 31
2015
Q2
$14M Buy
208,334
+62,805
+43% +$4.1M 0.83% 36
2015
Q1
$8.52M Buy
145,529
+35,202
+32% +$2.13M 0.55% 62
2014
Q4
$7.22M Buy
110,327
+1,580
+1% +$99.6K 0.48% 62
2014
Q3
$6.28M Sell
108,747
-581
-0.5% -$32.3K 0.43% 68
2014
Q2
$6.17M Buy
109,328
+4,295
+4% +$225K 0.43% 68
2014
Q1
$5.4M Buy
105,033
+862
+0.8% +$43.6K 0.39% 69
2013
Q4
$5.5M Sell
104,171
-9,517
-8% -$468K 0.41% 68
2013
Q3
$5.08M Buy
113,688
+7,433
+7% +$329K 0.42% 66
2013
Q2
$4.39M Buy
+106,255
New +$4.65M 0.39% 73

Other funds holding ABBV

Fiduciary Trust International of Pennsylvania's ABBV Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania increased its AbbVie (ABBV) stake by 1.3% in Q1 2020, buying an estimated $194K and bringing the position to 170,788 shares worth $13M. The position accounts for 0.61% of the portfolio, ranked #51.

Fiduciary Trust International of Pennsylvania first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. The position peaked at $24.3M in Q1 2018. 2,226 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Fiduciary Trust International of Pennsylvania held 170,788 shares of AbbVie worth $13M as of Q1 2020.
  • Fiduciary Trust International of Pennsylvania bought 2,274 AbbVie shares in Q1 2020, an estimated $194K.
  • AbbVie made up 0.61% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #51 holding.
  • Fiduciary Trust International of Pennsylvania first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
  • Fiduciary Trust International of Pennsylvania's AbbVie position peaked at $24.3M in Q1 2018.
  • 2,226 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.